NIH Summer Poster Day 2011 is scheduled for Thursday, August 4th 2011:
(It will be held in the Natcher Conference Center (Building 45) from 9:00 am to 3:00 pm. If you want to participate in Summer Poster Day, you must sign up in advance, and your mentor must approve your poster title. You can sign up to present a poster beginning June 1. The deadline to sign up is Wednesday, July 6 at 5:00 pm (EDT). All submissions must be approved by participants' preceptors by Friday, July 8 at 5:00 pm (EDT).)
440. Catherine W Cai Detection of Xenotropic Murine Leukemia Virus-Related Virus (XMRV) in Blood Cells of Sjögren's Syndrome Patients Emory University Hometown: Atlanta, GA Dr. Gabor Illei, Preceptor Molecular Physiology and Therapeutics Branch
https://www.training.nih.gov/summer_poster_day_2011
https://www.training.nih.gov/assets/Summer_Poster_Day_Program_2011.pdf
What can this mean Dr Speedy?Catherine Cai is editor of Emory university magazine while Dr Gabor is head of the NIH sjogrens syndrome clinic.If this is a real study then this is huge news!If this is just a fake poster presentation for a competition then it sucks and I hope she loses.
ReplyDeletefrom info provided on one of the links
ReplyDeleteSummer Poster Day is your time to share the research you have been conducting at the NIH and at the same time develop your communication and networking skills. Any student (high school, college, medical/dental, or graduate) working in an intramural research group this summer may present. You may not have final results. However, you can still present background information on your project, any data you may have collected, or a discussion of the technical problems you encountered.
Not sure from poster title if XMRV was found we have had many negative papers with similar titles. Does anybody know for sure if XMRV was detected
ReplyDeleteI asked Gabor Illei about the status of his research. That was his answer:
ReplyDeleteWe have done some preliminary studies trying to detect XMRV in DNA derived from peripheral blood of patients with Sjogren's syndrome and controls. We used PCR only and did all the experiments in house. The study cited on several internet sites was a presentation of a work in progress at an NIH event. Since then we have done some additional control experiments and now we believe that the findings were due to contamination. I am not aware of any other group looking at XMRV in Sjogren's.
I hope this helps,
Best regards,
Gabor Illei
So no XMRV in Sjögren's patients.